Stop misunderstanding it! Ping An Good Doctor isn't being overfed; it's genuinely healthier now.

Ask AI · How Ping An Good Doctor Achieves Profitability and High Growth Through Medical Insurance Collaboration

Produced by | China Investment Network

Reviewed by | Li Xiaoyan

In 2025, Ping An Good Doctor turned in a highly convincing set of results: total revenue in the first three quarters was 3.725 billion yuan, up 13.6%; net profit was 184 million yuan, up 72.6% year over year. After adjustment, net profit was 216 million yuan, up 45.7%. Two consecutive years of steady profitability, coupled with positive feedback from the capital markets, mark the company—once a heavy spender that had been in losses—moving into a new stage of high-quality development. Questions about the company “depending on the parent company for capital infusions” are being steadily disproved by its profitability, deeply implemented medical insurance collaboration, and rapidly growing AI and elderly-care businesses one by one. Ping An Good Doctor’s profitability is not simply “being fattened by funding,” but healthy, sustainable self-growth achieved by leveraging its ecosystem advantages.

The company’s performance surge is not a short-term coincidence, but the inevitable result of long-term strategic adjustments and refined operations. In 2024, the company achieved full-year profitability, ending a loss period that had lasted nine years. In the first three quarters of 2025, the growth rate of profitability further broke through 70%, with its profitability capability accelerating release. Judging from its financial structure, the company’s gross margin continued to improve, cost control delivered significant results, operating cash flow kept improving, and the profit resilience of its core business kept strengthening.

The capital markets have validated this growth with action: from September 2024 to September 2025, the company’s share price rose from HK$3.185 to HK$24.4, an increase of over 660%. Behind the valuation repair is the market’s recognition of the sustainability of the company’s profitability. Institutions including GF Securities issued “Buy” ratings, seeing the scarcity of its medical insurance collaboration and room for profit growth. Even if some institutions take a cautious view on the revenue structure, it is impossible to deny the company’s fundamental shift from “burning cash to acquire users” to “profit-driven” growth.

Of course, there are objective structural characteristics in the short term during enterprise development. The company’s stage-specific adjustments in accounts receivable and expense management and control are challenges commonly faced by the internet healthcare industry, not unique to Ping An Good Doctor. Compared with peers that continue to incur losses or have unclear business models, Ping An Good Doctor has already been the first to run through a profitable closed loop, with operational health clearly leading.

The market defines the combined revenue proportion of 78.3% from the F-side and B-side as simply “dependence on the parent company,” but this is actually a misreading of China’s internet healthcare business model. The collaboration between Ping An Good Doctor and Ping An Group is not a one-way “capital infusion,” but a two-way empowerment, an ecosystem closed loop of symbiosis and shared success. As the core carrier of Ping An Group’s “integrated finance + medical elderly care” strategy, Ping An Good Doctor serves the health needs of the Group’s 200 million+ financial customers, delivers professional medical services, and in return enhances the competitiveness of insurance products, reduces the claim ratio, and increases customer stickiness—forming a complete chain: “insurance user acquisition—medical and health services—customer retention—value conversion.”

This medical insurance collaboration model is Ping An Good Doctor’s core moat that sets it apart from platforms such as JD Health, Alibaba Health, and WeDoctor. Other platforms rely on public-market traffic and the margins from pharmaceutical e-commerce, facing dilemmas such as high customer-acquisition costs and difficulty achieving profitability. Meanwhile, Ping An Good Doctor relies on precise traffic within the ecosystem, resulting in lower customer-acquisition costs, higher user stickiness, and stronger willingness to pay. In the first half of 2025, F-side revenue was 1.433 billion yuan, up 28.5% year over year; B-side revenue was 527 million yuan, up 35.2%. It had over 4,500 enterprise customers. B-side paying users grew by 30.6%. Behind the data is recognition of the value of its services by enterprise customers and individual users—not merely the Group sending resources.

From an industry perspective, China’s healthcare market is led by public medical insurance, with commercial insurance as a supplement. Choosing medical insurance collaboration is a pragmatic choice aligned with the local market, and also a localized innovation of the U.S. HMO model. It does not pursue a wholesale replication of Kaiser Permanente’s integrated cost control. Instead, it is rooted in “insurance + services,” building a managed-care healthcare sample suitable for China’s national conditions. This strategic choice helps the company avoid homogeneous competition and chart a differentiated, sustainable development path.

In recent years, Ping An Good Doctor has achieved cost reduction and efficiency gains through personnel optimization and expense control, and some voices have interpreted this as “a shrinking of the front line.” In fact, this is a key measure in the company’s shift from extensive expansion to lean operations. From 2021 to 2024, personnel structure optimization focused on non-core areas, while R&D and front-line service resources continued to tilt toward core businesses. The stage-specific adjustment of R&D expenses in 2024 was based on reallocating resources according to business priorities, not on abandoning technical investment.

Leadership changes are also a proactive choice focused on strategic concentration and filling capability gaps. Guo Xiaotao took over as Chairman of the Board, strengthening strategic alignment within the Group; He Mingke became CEO, bringing experience in internet technology and product innovation, and covering the company’s shortcomings in AI and digitalization capabilities. Over a decade, strategic iteration—from competing for traffic on the C-side, to deepening focus on the B-side, and then to upgrading to “medical insurance collaboration + elderly care”—is essentially dynamic optimization that follows industry trends and concentrates on core capabilities, not strategic vacillation.

Stage-specific issues in executive compensation and service experience are management challenges in large-scale enterprise development. The company has continued to optimize its service processes and improve user satisfaction, and issues on platforms such as Hei Mao Complaints are gradually improving. As a leading industry platform, Ping An Good Doctor is applying stricter standards to regulate its services and safeguard its brand reputation—this is also an essential path for any enterprise to reach maturity.

If medical insurance collaboration is Ping An Good Doctor’s foundation, then AI healthcare and elderly-care services are its new engines for independent bloodline creation in the future. In the first half of 2025, the company’s revenue from elderly-care services grew 263.9% year over year. Amid the wave of the silver economy, the “medical, living, nursing, and leisure” at-home elderly-care system has been rapidly rolled out, becoming a strong driver of performance growth. Although the share of elderly-care revenue still has room to increase, the growth rate has already validated the potential of the track; it will become the third growth engine after the F-side and B-side.

AI technology is the core lever for cost reduction, efficiency gains, and service upgrades. The company launched a “7+N+1” AI medical product matrix, covering all scenarios such as an AI family doctor, an AI elderly-care concierge, and AI chronic disease management. Relying on the medical large model “Ping An Medical Bo Tong,” it enables end-to-end intelligence across consultation, diagnosis, and health management. With AI applications, the cost per family-doctor consultation for each user decreased by about 52%, and service efficiency increased by about 62%. This not only lowers operating costs, but also improves service accessibility, allowing high-quality medical resources to reach more users.

Unlike the industry’s typical “conceptual AI,” Ping An Good Doctor’s AI technology is rooted in real medical scenarios. It is trained based on online consultation data exceeding 1.44 billion records, and both diagnosis accuracy and service efficiency continue to improve. Stage-specific optimization of R&D investment does not affect the rollout and iteration of AI technology. On the contrary, it makes resources more focused on application scenarios that can generate commercial value, driving the transformation of the technology from “cost reduction” to “revenue growth.”

Ping An Good Doctor’s growth path clearly shows the breakthrough-to-survive solution for China’s internet healthcare companies: leverage ecosystem advantages to stand firm, build moats through medical insurance collaboration, open up space with AI and elderly care, and ultimately achieve a transformation from ecosystem collaboration to independent bloodline creation. What people call “dependence on the parent company” is essentially an early stage of ecosystem collaboration. And today’s high growth in profitability, diversified business lines, and technological innovation are the signs that it is moving toward independence and maturity.

Against the backdrop of major trends in China’s healthcare industry upgrading, accelerating aging, and the expansion of commercial medical insurance, Ping An Good Doctor’s strategic positioning is highly valuable. It is both Ping An’s “medical flagship” within the ecosystem and an independently operated healthcare platform. It grows steadily by leveraging collaboration, and also opens up long-term space through innovation. The underlying basis of this profitability performance is a comprehensive result of operational improvement, model innovation, and technology enablement—true “healthy growth,” not simply “being fattened.”

Looking ahead, as medical insurance collaboration deepens, AI technology is rolled out, and elderly-care business scales up, Ping An Good Doctor will further enhance its ability to acquire users independently and create its own “bloodline.” From Ping An’s “good son,” it will grow into the industry’s “good doctor,” creating greater value for users, shareholders, and the industry.